Literature DB >> 32253651

Sirt1-ROS-TRAF6 Signaling-Induced Pyroptosis Contributes to Early Injury in Ischemic Mice.

Weijie Yan1, Wei Sun2, Jiahui Fan1, Haiqing Wang2, Song Han1, Junfa Li1, Yanling Yin3.   

Abstract

Stroke is an acute cerebro-vascular disease with high incidence and poor prognosis, most commonly ischemic in nature. In recent years, increasing attention has been paid to inflammatory reactions as symptoms of a stroke. However, the role of inflammation in stroke and its underlying mechanisms require exploration. In this study, we evaluated the inflammatory reactions induced by acute ischemia and found that pyroptosis occurred after acute ischemia both in vivo and in vitro, as determined by interleukin-1β, apoptosis-associated speck-like protein, and caspase-1. The early inflammation resulted in irreversible ischemic injury, indicating that it deserves thorough investigation. Meanwhile, acute ischemia decreased the Sirtuin 1 (Sirt1) protein levels, and increased the TRAF6 (TNF receptor associated factor 6) protein and reactive oxygen species (ROS) levels. In further exploration, both Sirt1 suppression and TRAF6 activation were found to contribute to this pyroptosis. Reduced Sirt1 levels were responsible for the production of ROS and increased TRAF6 protein levels after ischemic exposure. Moreover, N-acetyl-L-cysteine, an ROS scavenger, suppressed the TRAF6 accumulation induced by oxygen-glucose deprivation via suppression of ROS bursts. These phenomena indicate that Sirt1 is upstream of ROS, and ROS bursts result in increased TRAF6 levels. Further, the activation of Sirt1 during the period of ischemia reduced ischemia-induced injury after 72 h of reperfusion in mice with middle cerebral artery occlusion. In sum, these results indicate that pyroptosis-dependent machinery contributes to the neural injury during acute ischemia via the Sirt1-ROS-TRAF6 signaling pathway. We propose that inflammatory reactions occur soon after oxidative stress and are detrimental to neuronal survival; this provides a promising therapeutic target against ischemic injuries such as a stroke.

Entities:  

Keywords:  Pyroptosis; ROS; Sirt1; Stroke; TRAF6

Mesh:

Substances:

Year:  2020        PMID: 32253651      PMCID: PMC7410906          DOI: 10.1007/s12264-020-00489-4

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  67 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation.

Authors:  Peleg Rider; Yaron Carmi; Ofer Guttman; Alex Braiman; Idan Cohen; Elena Voronov; Malka R White; Charles A Dinarello; Ron N Apte
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

3.  Increased expression of TNF receptor-associated factor 6 after rat traumatic brain injury.

Authors:  Jian Chen; Xiujie Wu; Bai Shao; Wei Zhao; Wei Shi; Shuangwei Zhang; Lanchun Ni; Aiguo Shen
Journal:  Cell Mol Neurobiol       Date:  2010-11-12       Impact factor: 5.046

4.  Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes.

Authors:  Alvin Lu; Venkat Giri Magupalli; Jianbin Ruan; Qian Yin; Maninjay K Atianand; Matthijn R Vos; Gunnar F Schröder; Katherine A Fitzgerald; Hao Wu; Edward H Egelman
Journal:  Cell       Date:  2014-03-13       Impact factor: 41.582

5.  Isoquercetin Ameliorates Cerebral Impairment in Focal Ischemia Through Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Effects in Primary Culture of Rat Hippocampal Neurons and Hippocampal CA1 Region of Rats.

Authors:  Cai-Ping Wang; Yun-Wei Shi; Miao Tang; Xiao-Chuan Zhang; Yun Gu; Xin-Miao Liang; Zhi-Wei Wang; Fei Ding
Journal:  Mol Neurobiol       Date:  2016-02-29       Impact factor: 5.590

Review 6.  Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Authors:  Muhammad Abdullah; Jessica M Berthiaume; Monte S Willis
Journal:  Transl Res       Date:  2017-11-07       Impact factor: 7.012

7.  Alteration in bioenergetic regulators, SirT1 and Parp1 expression precedes oxidative stress in rats subjected to transient cerebral focal ischemia: molecular and histopathologic evidences.

Authors:  Periyathambi Kalaivani; Murugan Ganesh; Sekar Sathiya; Vijayan Ranju; Veeraragavan Gayathiri; Chidambaram Saravana Babu
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-10-14       Impact factor: 2.136

8.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

10.  Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.

Authors:  Humayun Sharif; Li Wang; Wei Li Wang; Venkat Giri Magupalli; Liudmila Andreeva; Qi Qiao; Arthur V Hauenstein; Zhaolong Wu; Gabriel Núñez; Youdong Mao; Hao Wu
Journal:  Nature       Date:  2019-06-12       Impact factor: 49.962

View more
  4 in total

Review 1.  Targeting the epigenome in in-stent restenosis: from mechanisms to therapy.

Authors:  Xi Yang; Yanyan Yang; Junjie Guo; Yuanyuan Meng; Min Li; Panyu Yang; Xin Liu; Lynn Htet Htet Aung; Tao Yu; Yonghong Li
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-26       Impact factor: 8.886

Review 2.  Perspectives on the mechanism of pyroptosis after intracerebral hemorrhage.

Authors:  Dengpan Song; Chi-Tai Yeh; Jian Wang; Fuyou Guo
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

3.  TRAF6 Contributes to CFA-Induced Spinal Microglial Activation and Chronic Inflammatory Pain in Mice.

Authors:  Ying Lu; De-Li Cao; Ling-Jie Ma; Yong-Jing Gao
Journal:  Cell Mol Neurobiol       Date:  2021-03-10       Impact factor: 5.046

4.  LDHA-Mediated Glycolytic Metabolism in Nucleus Pulposus Cells Is a Potential Therapeutic Target for Intervertebral Disc Degeneration.

Authors:  Longxi Wu; Jieliang Shen; Xiaojun Zhang; Zhenming Hu
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.